Equities

Hellenic Dynamics PLC

HELD:LSE

Hellenic Dynamics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.78
  • Today's Change-0.225 / -11.25%
  • Shares traded8.03m
  • 1 Year change-88.55%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 16:21 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Income statement information is not available for Hellenic Dynamics PLC.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in GBPView more

In 2023, Hellenic Dynamics PLC increased its cash reserves by 42,074.50%, or 2.11m. Cash Flow from Investing totalled 1.68m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 294.68k for operations while cash generated from financing totalled 724.10k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.006
Tangible book value per share0.006
More ▼

Balance sheet in GBPView more

Hellenic Dynamics PLC appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.84% of the market capitalization can be attributed to its 2.12m and debt could be paid in full if management chose.
Current ratio0.6833
Quick ratio--
Total debt/total equity0.4345
Total debt/total capital0.3029
More ▼

Growth rates in GBP

Growth rate information is not available.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.